Every record from Janoshik · page 37
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-019003 | PT-141 (Bremelanotide) | FGP | FGP-2509-H2645 | 2025-Q4 | 99.91 | 3.17 | — | Supplier-supplied | 0 | PASS |
| AX-2025-018869 | TB-500 | QSC | QSC-2505-B8934 | 2025-Q3 | 99.66 | 4.10 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021106 | Tirzepatide | WXT | WXT-2505-T4814 | 2025-Q3 | 97.83 | 3.61 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021257 | Cagrilintide | BCH | BCH-2509-A6666 | 2025-Q4 | 99.57 | 5.99 | 107.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019123 | IGF-1 DES (1-3) | JEEP | JEEP-2510-M4682 | 2025-Q4 | 99.74 | 3.28 | 104.0 | Supplier-supplied | 0 | PASS |
| AX-2025-019004 | PT-141 (Bremelanotide) | FGP | FGP-2509-H2645 | 2025-Q4 | 99.93 | 3.59 | 93.4 | Supplier-supplied | 0 | PASS |
| AX-2025-020165 | Liraglutide | GGPeps | GGPE-2505-W9629 | 2025-Q4 | 98.18 | 7.21 | 104.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018449 | Melanotan II | WWB | WWB-2510-P2932 | 2025-Q4 | 99.72 | 4.96 | 95.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020096 | ARA-290 | GGPeps | GGPE-2511-F8277 | 2025-Q4 | 98.36 | 2.33 | — | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019589 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.93 | 6.33 | 105.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019216 | BPC-157 | TFC | TFC-2508-W5717 | 2025-Q3 | 99.32 | 3.74 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019190 | Tirzepatide | TFC | TFC-2507-T5380 | 2025-Q3 | 98.48 | 3.35 | 98.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020904 | Semaglutide | CPC | CPC-2504-G2724 | 2025-Q3 | 98.83 | 5.33 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020848 | SS-31 (Elamipretide) | CPC | CPC-2504-E1788 | 2025-Q3 | 98.18 | 4.51 | — | Supplier-supplied | 3 | FAIL |
| AX-2025-020836 | Melanotan II | SGN | SGN-2508-U1379 | 2025-Q3 | 98.30 | 3.45 | 92.5 | Buyer-sourced | 2 | FAIL |
| AX-2025-020206 | Enclomiphene citrate | GGPeps | GGPE-2510-H1237 | 2025-Q4 | 99.74 | 5.25 | 99.1 | Supplier-supplied | 1 | FAIL |
| AX-2025-020031 | CJC-1295 (no DAC) | ERP | ERP-2506-B7535 | 2025-Q4 | 99.29 | 5.43 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021318 | GHRP-2 | BCH | BCH-2506-L7534 | 2025-Q3 | 98.51 | 8.95 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020128 | Retatrutide | GGPeps | GGPE-2508-E8992 | 2025-Q3 | 98.07 | 2.26 | 100.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020117 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 98.58 | 5.63 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019810 | Semaglutide | HJ | HJ-2507-P3933 | 2025-Q3 | 99.04 | 4.12 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-019395 | Retatrutide | Homopeptide | HOMO-2508-Y8363 | 2025-Q4 | 98.28 | 6.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021067 | Liraglutide | WXT | WXT-2504-L4924 | 2025-Q3 | 96.59 | 6.57 | 98.0 | Supplier-supplied | 1 | FAIL |
| AX-2025-020113 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 97.52 | 6.10 | — | Laboratory-retained | 2 | MARGINAL |
| AX-2025-020109 | Tirzepatide | GGPeps | GGPE-2502-J8885 | 2025-Q3 | 97.54 | 6.26 | 103.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019737 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.53 | 7.19 | 106.2 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019630 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 99.03 | 6.06 | 94.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019804 | Semaglutide | HJ | HJ-2507-P3933 | 2025-Q3 | 99.58 | 4.24 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019689 | BPC-157 | HJ | HJ-2503-M3088 | 2025-Q3 | 99.93 | 4.84 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019518 | MK-677 (Ibutamoren mesylate) | Homopeptide | HOMO-2506-L9801 | 2025-Q4 | 99.93 | 1.97 | 88.8 | Supplier-supplied | 2 | FAIL |
| AX-2025-021307 | CJC-1295 with DAC | BCH | BCH-2505-T7755 | 2025-Q3 | 98.11 | 7.56 | 90.1 | Laboratory-retained | 2 | MARGINAL |
| AX-2025-019742 | Ipamorelin | HJ | HJ-2504-X2985 | 2025-Q3 | 99.08 | 7.15 | 99.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019113 | BPC-157 | JEEP | JEEP-2507-V4206 | 2025-Q3 | 99.34 | 4.39 | 90.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-021239 | L-Glutathione (reduced) | BCH | BCH-2508-X6429 | 2025-Q3 | 97.56 | 6.21 | 92.1 | Supplier-supplied | 0 | FAIL |
| AX-2025-020609 | Retatrutide | SSA | SSA-2507-W7338 | 2025-Q3 | 97.98 | 3.29 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020290 | 5-Amino-1MQ | MKM | MKM-2503-H2930 | 2025-Q3 | 99.93 | 5.46 | 106.4 | Supplier-supplied | 1 | FAIL |
| AX-2025-019981 | Semaglutide | ERP | ERP-2508-S6110 | 2025-Q3 | 98.79 | 2.77 | 92.5 | Buyer-sourced | 0 | PASS |
| AX-2025-020887 | BPC-157 | CPC | CPC-2503-T1811 | 2025-Q3 | 99.05 | 4.19 | 100.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019424 | Semaglutide | Homopeptide | HOMO-2505-V8950 | 2025-Q3 | 99.03 | 5.86 | 94.6 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019377 | Tirzepatide | TFC | TFC-2503-P7552 | 2025-Q3 | 99.16 | 4.83 | 88.6 | Supplier-supplied | 2 | MARGINAL |